Wave Life Sciences Usa, Inc.
Clinical trials sponsored by Wave Life Sciences Usa, Inc., explained in plain language.
A biotech company developing RNA-based therapies for genetic diseases.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New injection aims to tackle obesity – early human trial begins
Disease control Recruiting nowThis early-stage study tests a new drug, WVE-007, given as a shot under the skin to help with weight loss. It includes about 296 adults who are overweight or have obesity, some with pre-diabetes or type 2 diabetes. The main goal is to check safety and how the drug moves through t…
Phase: PHASE1, PHASE2 • Sponsor: Wave Life Sciences USA, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for duchenne: experimental drug aims to restore muscle protein
Disease control Recruiting nowThis study tests an experimental drug called WVE-N531 in 26 people with Duchenne muscular dystrophy who have a specific genetic flaw (exon 53 mutation). The drug is designed to help the body make a shortened but working version of dystrophin, a protein missing in DMD. The trial w…
Phase: PHASE1, PHASE2 • Sponsor: Wave Life Sciences USA, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC